APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Proteomics Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plasma Proteomics Service Market Analysis and Forecast 2026-2032

12 August 2026199 pages

Choose your research edition.

Industry ResearchPlasma Proteomics Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Proteomics Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Plasma Proteomics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Proteomics Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Proteomics Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Plasma Proteomics Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plasma Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasma Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasma Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasma Proteomics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plasma Proteomics Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plasma Proteomics Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma Proteomics Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma Proteomics Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma Proteomics Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Proteomics Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma Proteomics Service revenue, projected growth trends, production technology, application and end-user industry.

Plasma Proteomics Service Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Plasma Proteomics Service Segment by Type

Discovery Plasma Proteomics

DIA Plasma Proteomics

TMT Plasma Proteomics

Targeted Plasma Proteomics

Others

Plasma Proteomics Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Plasma Proteomics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Proteomics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasma Proteomics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasma Proteomics Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Proteomics Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma Proteomics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Discovery Plasma Proteomics Major Player Table 3. DIA Plasma Proteomics Major Player Table 4. TMT Plasma Proteomics Major Player Table 5. Targeted Plasma Proteomics Major Player Table 6. Others Major Player Table 7. Global Plasma Proteomics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Disease Biomarker Research Major Player Table 9. Drug Development Major Player Table 10. Clinical Research Major Player Table 11. Others Major Player Table 12. Plasma Proteomics Service Industry Trends Table 13. Plasma Proteomics Service Industry Drivers Table 14. Plasma Proteomics Service Industry Opportunities and Challenges Table 15. Plasma Proteomics Service Industry Restraints Table 16. Global Plasma Proteomics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Plasma Proteomics Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Plasma Proteomics Service Market Share by Region (2021-2026) Table 19. Global Plasma Proteomics Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Plasma Proteomics Service Market Share by Region (2027-2032) Table 21. Global Plasma Proteomics Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Plasma Proteomics Service Revenue Market Share by Players (2021-2026) Table 23. Global Plasma Proteomics Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Plasma Proteomics Service Key Players Headquarters & Area Served Table 25. Global Plasma Proteomics Service Players, Product Type & Application Table 26. Global Plasma Proteomics Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Plasma Proteomics Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Plasma Proteomics Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Plasma Proteomics Service Revenue Market Share by Type (2021-2026) Table 33. Global Plasma Proteomics Service Revenue Market Share by Type (2027-2032) Table 34. Global Plasma Proteomics Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Plasma Proteomics Service Revenue Market Share by Application (2021-2026) Table 38. Global Plasma Proteomics Service Revenue Market Share by Application (2027-2032) Table 39. BostonGene Company Information Table 40. BostonGene Business Overview Table 41. BostonGene Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. BostonGene Plasma Proteomics Service Product Portfolio Table 43. BostonGene Recent Development Table 44. CellCarta Company Information Table 45. CellCarta Business Overview Table 46. CellCarta Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. CellCarta Plasma Proteomics Service Product Portfolio Table 48. CellCarta Recent Development Table 49. GENEWIZ (Azenta Life Sciences) Company Information Table 50. GENEWIZ (Azenta Life Sciences) Business Overview Table 51. GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Product Portfolio Table 53. GENEWIZ (Azenta Life Sciences) Recent Development Table 54. CDI Labs Company Information Table 55. CDI Labs Business Overview Table 56. CDI Labs Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. CDI Labs Plasma Proteomics Service Product Portfolio Table 58. CDI Labs Recent Development Table 59. Biognosys Company Information Table 60. Biognosys Business Overview Table 61. Biognosys Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Biognosys Plasma Proteomics Service Product Portfolio Table 63. Biognosys Recent Development Table 64. Discovery Life Sciences Company Information Table 65. Discovery Life Sciences Business Overview Table 66. Discovery Life Sciences Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Discovery Life Sciences Plasma Proteomics Service Product Portfolio Table 68. Discovery Life Sciences Recent Development Table 69. Firalis Molecular Precision Company Information Table 70. Firalis Molecular Precision Business Overview Table 71. Firalis Molecular Precision Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Firalis Molecular Precision Plasma Proteomics Service Product Portfolio Table 73. Firalis Molecular Precision Recent Development Table 74. Cell Signaling Technology (CST) Company Information Table 75. Cell Signaling Technology (CST) Business Overview Table 76. Cell Signaling Technology (CST) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Cell Signaling Technology (CST) Plasma Proteomics Service Product Portfolio Table 78. Cell Signaling Technology (CST) Recent Development Table 79. Sampled (Infinity Biologix) Company Information Table 80. Sampled (Infinity Biologix) Business Overview Table 81. Sampled (Infinity Biologix) Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Sampled (Infinity Biologix) Plasma Proteomics Service Product Portfolio Table 83. Sampled (Infinity Biologix) Recent Development Table 84. APTBIO Company Information Table 85. APTBIO Business Overview Table 86. APTBIO Plasma Proteomics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. APTBIO Plasma Proteomics Service Product Portfolio Table 88. APTBIO Recent Development Table 89. Sinotech Genomics Company Information Table 90. Sinotech Genomics Business Overview Table 91. Sinotech Genomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sinotech Genomics Plasma Proteomics Service Product Portfolio Table 93. Sinotech Genomics Recent Development Table 94. Biodesix Company Information Table 95. Biodesix Business Overview Table 96. Biodesix Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Biodesix Plasma Proteomics Service Product Portfolio Table 98. Biodesix Recent Development Table 99. Panome Bio Company Information Table 100. Panome Bio Business Overview Table 101. Panome Bio Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Panome Bio Plasma Proteomics Service Product Portfolio Table 103. Panome Bio Recent Development Table 104. Novogene Company Information Table 105. Novogene Business Overview Table 106. Novogene Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Novogene Plasma Proteomics Service Product Portfolio Table 108. Novogene Recent Development Table 109. PTM BIO Company Information Table 110. PTM BIO Business Overview Table 111. PTM BIO Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. PTM BIO Plasma Proteomics Service Product Portfolio Table 113. PTM BIO Recent Development Table 114. BGI Genomics Company Information Table 115. BGI Genomics Business Overview Table 116. BGI Genomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BGI Genomics Plasma Proteomics Service Product Portfolio Table 118. BGI Genomics Recent Development Table 119. Evotec Company Information Table 120. Evotec Business Overview Table 121. Evotec Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Evotec Plasma Proteomics Service Product Portfolio Table 123. Evotec Recent Development Table 124. Metware Biotechnology Company Information Table 125. Metware Biotechnology Business Overview Table 126. Metware Biotechnology Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Metware Biotechnology Plasma Proteomics Service Product Portfolio Table 128. Metware Biotechnology Recent Development Table 129. MRM Proteomics Company Information Table 130. MRM Proteomics Business Overview Table 131. MRM Proteomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. MRM Proteomics Plasma Proteomics Service Product Portfolio Table 133. MRM Proteomics Recent Development Table 134. Lc-Bio Technologies Company Information Table 135. Lc-Bio Technologies Business Overview Table 136. Lc-Bio Technologies Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Lc-Bio Technologies Plasma Proteomics Service Product Portfolio Table 138. Lc-Bio Technologies Recent Development Table 139. Eurofins Scientific Company Information Table 140. Eurofins Scientific Business Overview Table 141. Eurofins Scientific Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Eurofins Scientific Plasma Proteomics Service Product Portfolio Table 143. Eurofins Scientific Recent Development Table 144. MtoZ-Biolabs Company Information Table 145. MtoZ-Biolabs Business Overview Table 146. MtoZ-Biolabs Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. MtoZ-Biolabs Plasma Proteomics Service Product Portfolio Table 148. MtoZ-Biolabs Recent Development Table 149. Creative Proteomics Company Information Table 150. Creative Proteomics Business Overview Table 151. Creative Proteomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Creative Proteomics Plasma Proteomics Service Product Portfolio Table 153. Creative Proteomics Recent Development Table 154. Macrogen Company Information Table 155. Macrogen Business Overview Table 156. Macrogen Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Macrogen Plasma Proteomics Service Product Portfolio Table 158. Macrogen Recent Development Table 159. TATAA Biocenter Company Information Table 160. TATAA Biocenter Business Overview Table 161. TATAA Biocenter Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. TATAA Biocenter Plasma Proteomics Service Product Portfolio Table 163. TATAA Biocenter Recent Development Table 164. OmicScouts (Momentum Biotechnologies) Company Information Table 165. OmicScouts (Momentum Biotechnologies) Business Overview Table 166. OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Product Portfolio Table 168. OmicScouts (Momentum Biotechnologies) Recent Development Table 169. Precision Biomarker Laboratories (PBL) Company Information Table 170. Precision Biomarker Laboratories (PBL) Business Overview Table 171. Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Product Portfolio Table 173. Precision Biomarker Laboratories (PBL) Recent Development Table 174. Shanghai OE Biotech Company Information Table 175. Shanghai OE Biotech Business Overview Table 176. Shanghai OE Biotech Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 177. Shanghai OE Biotech Plasma Proteomics Service Product Portfolio Table 178. Shanghai OE Biotech Recent Development Table 179. RxCelerate Company Information Table 180. RxCelerate Business Overview Table 181. RxCelerate Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 182. RxCelerate Plasma Proteomics Service Product Portfolio Table 183. RxCelerate Recent Development Table 184. Proteomics International Company Information Table 185. Proteomics International Business Overview Table 186. Proteomics International Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 187. Proteomics International Plasma Proteomics Service Product Portfolio Table 188. Proteomics International Recent Development Table 189. Proteome Sciences Company Information Table 190. Proteome Sciences Business Overview Table 191. Proteome Sciences Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 192. Proteome Sciences Plasma Proteomics Service Product Portfolio Table 193. Proteome Sciences Recent Development Table 194. Westlake Omics Company Information Table 195. Westlake Omics Business Overview Table 196. Westlake Omics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 197. Westlake Omics Plasma Proteomics Service Product Portfolio Table 198. Westlake Omics Recent Development Table 199. Crown Bioscience Company Information Table 200. Crown Bioscience Business Overview Table 201. Crown Bioscience Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 202. Crown Bioscience Plasma Proteomics Service Product Portfolio Table 203. Crown Bioscience Recent Development Table 204. VProteomics Company Information Table 205. VProteomics Business Overview Table 206. VProteomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 207. VProteomics Plasma Proteomics Service Product Portfolio Table 208. VProteomics Recent Development Table 209. Shanghai Majorbio Bio-Pharm Company Information Table 210. Shanghai Majorbio Bio-Pharm Business Overview Table 211. Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 212. Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Product Portfolio Table 213. Shanghai Majorbio Bio-Pharm Recent Development Table 214. Applied Biomics Company Information Table 215. Applied Biomics Business Overview Table 216. Applied Biomics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 217. Applied Biomics Plasma Proteomics Service Product Portfolio Table 218. Applied Biomics Recent Development Table 219. Sapient Bioanalytics Company Information Table 220. Sapient Bioanalytics Business Overview Table 221. Sapient Bioanalytics Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 222. Sapient Bioanalytics Plasma Proteomics Service Product Portfolio Table 223. Sapient Bioanalytics Recent Development Table 224. Allumiqs Company Information Table 225. Allumiqs Business Overview Table 226. Allumiqs Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 227. Allumiqs Plasma Proteomics Service Product Portfolio Table 228. Allumiqs Recent Development Table 229. MS Bioworks Company Information Table 230. MS Bioworks Business Overview Table 231. MS Bioworks Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 232. MS Bioworks Plasma Proteomics Service Product Portfolio Table 233. MS Bioworks Recent Development Table 234. Shanghai Bioprofile Company Information Table 235. Shanghai Bioprofile Business Overview Table 236. Shanghai Bioprofile Plasma Proteomics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 237. Shanghai Bioprofile Plasma Proteomics Service Product Portfolio Table 238. Shanghai Bioprofile Recent Development Table 239. North America Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 240. North America Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 241. North America Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 242. North America Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 243. North America Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. North America Plasma Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 245. North America Plasma Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 246. Europe Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 247. Europe Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 248. Europe Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 249. Europe Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 250. Europe Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. Europe Plasma Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 252. Europe Plasma Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 253. China Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 254. China Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 255. China Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 256. China Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 257. Asia Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 258. Asia Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 259. Asia Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 260. Asia Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 261. Asia Plasma Proteomics Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 262. Asia Plasma Proteomics Service Revenue by Region (US$ Million) & (2021-2026) Table 263. Asia Plasma Proteomics Service Revenue by Region (US$ Million) & (2027-2032) Table 264. SAMEA Plasma Proteomics Service Revenue by Type (2021-2026) & (US$ Million) Table 265. SAMEA Plasma Proteomics Service Revenue by Type (2027-2032) & (US$ Million) Table 266. SAMEA Plasma Proteomics Service Revenue by Application (2021-2026) & (US$ Million) Table 267. SAMEA Plasma Proteomics Service Revenue by Application (2027-2032) & (US$ Million) Table 268. SAMEA Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 269. SAMEA Plasma Proteomics Service Revenue by Country (2021-2026) & (US$ Million) Table 270. SAMEA Plasma Proteomics Service Revenue by Country (US$ Million) & (2027-2032) Table 271. Research Programs/Design for This Report Table 272. Authors List of This Report Table 273. Secondary Sources Table 274. Primary Sources List of Figures Figure 1. Plasma Proteomics Service Image Figure 2. Global Plasma Proteomics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Proteomics Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Discovery Plasma Proteomics Image Figure 5. DIA Plasma Proteomics Image Figure 6. TMT Plasma Proteomics Image Figure 7. Targeted Plasma Proteomics Image Figure 8. Others Image Figure 9. Global Plasma Proteomics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Plasma Proteomics Service Market Size Share 2021 VS 2025 VS 2032 Figure 11. Disease Biomarker Research Image Figure 12. Drug Development Image Figure 13. Clinical Research Image Figure 14. Others Image Figure 15. Global Plasma Proteomics Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Plasma Proteomics Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Plasma Proteomics Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Plasma Proteomics Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Plasma Proteomics Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plasma Proteomics Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Plasma Proteomics Service Revenue Market Share by Type (2021-2032) Figure 23. Global Plasma Proteomics Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Plasma Proteomics Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Plasma Proteomics Service Revenue Market Share by Application (2021-2032) Figure 26. North America Plasma Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Plasma Proteomics Service Revenue Share by Type (2021-2032) Figure 28. North America Plasma Proteomics Service Revenue Share by Application (2021-2032) Figure 29. North America Plasma Proteomics Service Revenue Share by Country (2021-2032) Figure 30. United States Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Plasma Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Plasma Proteomics Service Revenue Share by Type (2021-2032) Figure 35. Europe Plasma Proteomics Service Revenue Share by Application (2021-2032) Figure 36. Europe Plasma Proteomics Service Revenue Share by Country (2021-2032) Figure 37. Germany Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Plasma Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Plasma Proteomics Service Revenue Share by Type (2021-2032) Figure 47. China Plasma Proteomics Service Revenue Share by Application (2021-2032) Figure 48. Asia Plasma Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Plasma Proteomics Service Revenue Share by Type (2021-2032) Figure 50. Asia Plasma Proteomics Service Revenue Share by Application (2021-2032) Figure 51. Asia Plasma Proteomics Service Revenue Share by Region (2021-2032) Figure 52. Japan Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Plasma Proteomics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Plasma Proteomics Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Plasma Proteomics Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Plasma Proteomics Service Revenue Share by Country (2021-2032) Figure 62. Brazil Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Plasma Proteomics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Discovery Plasma Proteomics
  • DIA Plasma Proteomics
  • TMT Plasma Proteomics
  • Targeted Plasma Proteomics
  • Others
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma Proteomics Service Market by Type
  3. 1.2.1 Global Plasma Proteomics Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Discovery Plasma Proteomics
  5. 1.2.3 DIA Plasma Proteomics
  6. 1.2.4 TMT Plasma Proteomics
  7. 1.2.5 Targeted Plasma Proteomics
  8. 1.2.6 Others
  9. 1.3 Plasma Proteomics Service Market by Application
  10. 1.3.1 Global Plasma Proteomics Service Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Disease Biomarker Research
  12. 1.3.3 Drug Development
  13. 1.3.4 Clinical Research
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Plasma Proteomics Service Market Dynamics
  1. 2.1 Plasma Proteomics Service Industry Trends
  2. 2.2 Plasma Proteomics Service Industry Drivers
  3. 2.3 Plasma Proteomics Service Industry Opportunities and Challenges
  4. 2.4 Plasma Proteomics Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasma Proteomics Service Market Perspective (2021-2032)
  2. 3.2 Global Plasma Proteomics Service Growth Trends by Region
  3. 3.2.1 Global Plasma Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma Proteomics Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasma Proteomics Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasma Proteomics Service Revenue by Players
  2. 4.1.1 Global Plasma Proteomics Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasma Proteomics Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasma Proteomics Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma Proteomics Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasma Proteomics Service Key Players Headquarters & Area Served
  7. 4.4 Global Plasma Proteomics Service Players, Product Type & Application
  8. 4.5 Global Plasma Proteomics Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasma Proteomics Service Market CR5 and HHI
  11. 4.6.3 2025 Plasma Proteomics Service Tier 1, Tier 2, and Tier 3
5 Plasma Proteomics Service Market Size by Type
  1. 5.1 Global Plasma Proteomics Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 5.3 Global Plasma Proteomics Service Revenue Market Share by Type (2021-2032)
6 Plasma Proteomics Service Market Size by Application
  1. 6.1 Global Plasma Proteomics Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasma Proteomics Service Revenue by Application (2021-2032)
  3. 6.3 Global Plasma Proteomics Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BostonGene
  2. 7.1.1 BostonGene Company Information
  3. 7.1.2 BostonGene Business Overview
  4. 7.1.3 BostonGene Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BostonGene Plasma Proteomics Service Product Portfolio
  6. 7.1.5 BostonGene Recent Developments
  7. 7.2 CellCarta
  8. 7.2.1 CellCarta Company Information
  9. 7.2.2 CellCarta Business Overview
  10. 7.2.3 CellCarta Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CellCarta Plasma Proteomics Service Product Portfolio
  12. 7.2.5 CellCarta Recent Developments
  13. 7.3 GENEWIZ (Azenta Life Sciences)
  14. 7.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 7.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 7.3.3 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GENEWIZ (Azenta Life Sciences) Plasma Proteomics Service Product Portfolio
  18. 7.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 7.4 CDI Labs
  20. 7.4.1 CDI Labs Company Information
  21. 7.4.2 CDI Labs Business Overview
  22. 7.4.3 CDI Labs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CDI Labs Plasma Proteomics Service Product Portfolio
  24. 7.4.5 CDI Labs Recent Developments
  25. 7.5 Biognosys
  26. 7.5.1 Biognosys Company Information
  27. 7.5.2 Biognosys Business Overview
  28. 7.5.3 Biognosys Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biognosys Plasma Proteomics Service Product Portfolio
  30. 7.5.5 Biognosys Recent Developments
  31. 7.6 Discovery Life Sciences
  32. 7.6.1 Discovery Life Sciences Company Information
  33. 7.6.2 Discovery Life Sciences Business Overview
  34. 7.6.3 Discovery Life Sciences Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Discovery Life Sciences Plasma Proteomics Service Product Portfolio
  36. 7.6.5 Discovery Life Sciences Recent Developments
  37. 7.7 Firalis Molecular Precision
  38. 7.7.1 Firalis Molecular Precision Company Information
  39. 7.7.2 Firalis Molecular Precision Business Overview
  40. 7.7.3 Firalis Molecular Precision Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Firalis Molecular Precision Plasma Proteomics Service Product Portfolio
  42. 7.7.5 Firalis Molecular Precision Recent Developments
  43. 7.8 Cell Signaling Technology (CST)
  44. 7.8.1 Cell Signaling Technology (CST) Company Information
  45. 7.8.2 Cell Signaling Technology (CST) Business Overview
  46. 7.8.3 Cell Signaling Technology (CST) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cell Signaling Technology (CST) Plasma Proteomics Service Product Portfolio
  48. 7.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 7.9 Sampled (Infinity Biologix)
  50. 7.9.1 Sampled (Infinity Biologix) Company Information
  51. 7.9.2 Sampled (Infinity Biologix) Business Overview
  52. 7.9.3 Sampled (Infinity Biologix) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sampled (Infinity Biologix) Plasma Proteomics Service Product Portfolio
  54. 7.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 7.10 APTBIO
  56. 7.10.1 APTBIO Company Information
  57. 7.10.2 APTBIO Business Overview
  58. 7.10.3 APTBIO Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 APTBIO Plasma Proteomics Service Product Portfolio
  60. 7.10.5 APTBIO Recent Developments
  61. 7.11 Sinotech Genomics
  62. 7.11.1 Sinotech Genomics Company Information
  63. 7.11.2 Sinotech Genomics Business Overview
  64. 7.11.3 Sinotech Genomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sinotech Genomics Plasma Proteomics Service Product Portfolio
  66. 7.11.5 Sinotech Genomics Recent Developments
  67. 7.12 Biodesix
  68. 7.12.1 Biodesix Company Information
  69. 7.12.2 Biodesix Business Overview
  70. 7.12.3 Biodesix Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biodesix Plasma Proteomics Service Product Portfolio
  72. 7.12.5 Biodesix Recent Developments
  73. 7.13 Panome Bio
  74. 7.13.1 Panome Bio Company Information
  75. 7.13.2 Panome Bio Business Overview
  76. 7.13.3 Panome Bio Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Panome Bio Plasma Proteomics Service Product Portfolio
  78. 7.13.5 Panome Bio Recent Developments
  79. 7.14 Novogene
  80. 7.14.1 Novogene Company Information
  81. 7.14.2 Novogene Business Overview
  82. 7.14.3 Novogene Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novogene Plasma Proteomics Service Product Portfolio
  84. 7.14.5 Novogene Recent Developments
  85. 7.15 PTM BIO
  86. 7.15.1 PTM BIO Company Information
  87. 7.15.2 PTM BIO Business Overview
  88. 7.15.3 PTM BIO Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 PTM BIO Plasma Proteomics Service Product Portfolio
  90. 7.15.5 PTM BIO Recent Developments
  91. 7.16 BGI Genomics
  92. 7.16.1 BGI Genomics Company Information
  93. 7.16.2 BGI Genomics Business Overview
  94. 7.16.3 BGI Genomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Genomics Plasma Proteomics Service Product Portfolio
  96. 7.16.5 BGI Genomics Recent Developments
  97. 7.17 Evotec
  98. 7.17.1 Evotec Company Information
  99. 7.17.2 Evotec Business Overview
  100. 7.17.3 Evotec Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Evotec Plasma Proteomics Service Product Portfolio
  102. 7.17.5 Evotec Recent Developments
  103. 7.18 Metware Biotechnology
  104. 7.18.1 Metware Biotechnology Company Information
  105. 7.18.2 Metware Biotechnology Business Overview
  106. 7.18.3 Metware Biotechnology Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Metware Biotechnology Plasma Proteomics Service Product Portfolio
  108. 7.18.5 Metware Biotechnology Recent Developments
  109. 7.19 MRM Proteomics
  110. 7.19.1 MRM Proteomics Company Information
  111. 7.19.2 MRM Proteomics Business Overview
  112. 7.19.3 MRM Proteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MRM Proteomics Plasma Proteomics Service Product Portfolio
  114. 7.19.5 MRM Proteomics Recent Developments
  115. 7.20 Lc-Bio Technologies
  116. 7.20.1 Lc-Bio Technologies Company Information
  117. 7.20.2 Lc-Bio Technologies Business Overview
  118. 7.20.3 Lc-Bio Technologies Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Lc-Bio Technologies Plasma Proteomics Service Product Portfolio
  120. 7.20.5 Lc-Bio Technologies Recent Developments
  121. 7.21 Eurofins Scientific
  122. 7.21.1 Eurofins Scientific Company Information
  123. 7.21.2 Eurofins Scientific Business Overview
  124. 7.21.3 Eurofins Scientific Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Eurofins Scientific Plasma Proteomics Service Product Portfolio
  126. 7.21.5 Eurofins Scientific Recent Developments
  127. 7.22 MtoZ-Biolabs
  128. 7.22.1 MtoZ-Biolabs Company Information
  129. 7.22.2 MtoZ-Biolabs Business Overview
  130. 7.22.3 MtoZ-Biolabs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 MtoZ-Biolabs Plasma Proteomics Service Product Portfolio
  132. 7.22.5 MtoZ-Biolabs Recent Developments
  133. 7.23 Creative Proteomics
  134. 7.23.1 Creative Proteomics Company Information
  135. 7.23.2 Creative Proteomics Business Overview
  136. 7.23.3 Creative Proteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Creative Proteomics Plasma Proteomics Service Product Portfolio
  138. 7.23.5 Creative Proteomics Recent Developments
  139. 7.24 Macrogen
  140. 7.24.1 Macrogen Company Information
  141. 7.24.2 Macrogen Business Overview
  142. 7.24.3 Macrogen Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Macrogen Plasma Proteomics Service Product Portfolio
  144. 7.24.5 Macrogen Recent Developments
  145. 7.25 TATAA Biocenter
  146. 7.25.1 TATAA Biocenter Company Information
  147. 7.25.2 TATAA Biocenter Business Overview
  148. 7.25.3 TATAA Biocenter Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  149. 7.25.4 TATAA Biocenter Plasma Proteomics Service Product Portfolio
  150. 7.25.5 TATAA Biocenter Recent Developments
  151. 7.26 OmicScouts (Momentum Biotechnologies)
  152. 7.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 7.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 7.26.3 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  155. 7.26.4 OmicScouts (Momentum Biotechnologies) Plasma Proteomics Service Product Portfolio
  156. 7.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 7.27 Precision Biomarker Laboratories (PBL)
  158. 7.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 7.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 7.27.3 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Precision Biomarker Laboratories (PBL) Plasma Proteomics Service Product Portfolio
  162. 7.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 7.28 Shanghai OE Biotech
  164. 7.28.1 Shanghai OE Biotech Company Information
  165. 7.28.2 Shanghai OE Biotech Business Overview
  166. 7.28.3 Shanghai OE Biotech Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Shanghai OE Biotech Plasma Proteomics Service Product Portfolio
  168. 7.28.5 Shanghai OE Biotech Recent Developments
  169. 7.29 RxCelerate
  170. 7.29.1 RxCelerate Company Information
  171. 7.29.2 RxCelerate Business Overview
  172. 7.29.3 RxCelerate Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  173. 7.29.4 RxCelerate Plasma Proteomics Service Product Portfolio
  174. 7.29.5 RxCelerate Recent Developments
  175. 7.30 Proteomics International
  176. 7.30.1 Proteomics International Company Information
  177. 7.30.2 Proteomics International Business Overview
  178. 7.30.3 Proteomics International Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Proteomics International Plasma Proteomics Service Product Portfolio
  180. 7.30.5 Proteomics International Recent Developments
  181. 7.31 Proteome Sciences
  182. 7.31.1 Proteome Sciences Company Information
  183. 7.31.2 Proteome Sciences Business Overview
  184. 7.31.3 Proteome Sciences Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Proteome Sciences Plasma Proteomics Service Product Portfolio
  186. 7.31.5 Proteome Sciences Recent Developments
  187. 7.32 Westlake Omics
  188. 7.32.1 Westlake Omics Company Information
  189. 7.32.2 Westlake Omics Business Overview
  190. 7.32.3 Westlake Omics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Westlake Omics Plasma Proteomics Service Product Portfolio
  192. 7.32.5 Westlake Omics Recent Developments
  193. 7.33 Crown Bioscience
  194. 7.33.1 Crown Bioscience Company Information
  195. 7.33.2 Crown Bioscience Business Overview
  196. 7.33.3 Crown Bioscience Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Crown Bioscience Plasma Proteomics Service Product Portfolio
  198. 7.33.5 Crown Bioscience Recent Developments
  199. 7.34 VProteomics
  200. 7.34.1 VProteomics Company Information
  201. 7.34.2 VProteomics Business Overview
  202. 7.34.3 VProteomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  203. 7.34.4 VProteomics Plasma Proteomics Service Product Portfolio
  204. 7.34.5 VProteomics Recent Developments
  205. 7.35 Shanghai Majorbio Bio-Pharm
  206. 7.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 7.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 7.35.3 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Shanghai Majorbio Bio-Pharm Plasma Proteomics Service Product Portfolio
  210. 7.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 7.36 Applied Biomics
  212. 7.36.1 Applied Biomics Company Information
  213. 7.36.2 Applied Biomics Business Overview
  214. 7.36.3 Applied Biomics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Applied Biomics Plasma Proteomics Service Product Portfolio
  216. 7.36.5 Applied Biomics Recent Developments
  217. 7.37 Sapient Bioanalytics
  218. 7.37.1 Sapient Bioanalytics Company Information
  219. 7.37.2 Sapient Bioanalytics Business Overview
  220. 7.37.3 Sapient Bioanalytics Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Sapient Bioanalytics Plasma Proteomics Service Product Portfolio
  222. 7.37.5 Sapient Bioanalytics Recent Developments
  223. 7.38 Allumiqs
  224. 7.38.1 Allumiqs Company Information
  225. 7.38.2 Allumiqs Business Overview
  226. 7.38.3 Allumiqs Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Allumiqs Plasma Proteomics Service Product Portfolio
  228. 7.38.5 Allumiqs Recent Developments
  229. 7.39 MS Bioworks
  230. 7.39.1 MS Bioworks Company Information
  231. 7.39.2 MS Bioworks Business Overview
  232. 7.39.3 MS Bioworks Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  233. 7.39.4 MS Bioworks Plasma Proteomics Service Product Portfolio
  234. 7.39.5 MS Bioworks Recent Developments
  235. 7.40 Shanghai Bioprofile
  236. 7.40.1 Shanghai Bioprofile Company Information
  237. 7.40.2 Shanghai Bioprofile Business Overview
  238. 7.40.3 Shanghai Bioprofile Plasma Proteomics Service Revenue and Gross Margin (2021-2026)
  239. 7.40.4 Shanghai Bioprofile Plasma Proteomics Service Product Portfolio
  240. 7.40.5 Shanghai Bioprofile Recent Developments
  241. 7.41 Cosmos Wisdom
  242. 7.42 Olink (Thermo Fisher Scientific)
  243. 7.43 SomaLogic (Illumina)
  244. 7.44 Labcorp
8 North America
  1. 8.1 North America Plasma Proteomics Service Revenue (2021-2032)
  2. 8.2 North America Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasma Proteomics Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasma Proteomics Service Revenue by Type (2027-2032)
  5. 8.3 North America Plasma Proteomics Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasma Proteomics Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasma Proteomics Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasma Proteomics Service Revenue by Application (2027-2032)
  9. 8.5 North America Plasma Proteomics Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasma Proteomics Service Revenue by Country
  11. 8.6.1 North America Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasma Proteomics Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasma Proteomics Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Plasma Proteomics Service Revenue (2021-2032)
  2. 9.2 Europe Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasma Proteomics Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasma Proteomics Service Revenue by Type (2027-2032)
  5. 9.3 Europe Plasma Proteomics Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasma Proteomics Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasma Proteomics Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasma Proteomics Service Revenue by Application (2027-2032)
  9. 9.5 Europe Plasma Proteomics Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasma Proteomics Service Revenue by Country
  11. 9.6.1 Europe Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasma Proteomics Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasma Proteomics Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Plasma Proteomics Service Revenue (2021-2032)
  2. 10.2 China Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 10.2.1 China Plasma Proteomics Service Revenue by Type (2021-2026)
  4. 10.2.2 China Plasma Proteomics Service Revenue by Type (2027-2032)
  5. 10.3 China Plasma Proteomics Service Revenue Share by Type (2021-2032)
  6. 10.4 China Plasma Proteomics Service Revenue by Application (2021-2032)
  7. 10.4.1 China Plasma Proteomics Service Revenue by Application (2021-2026)
  8. 10.4.2 China Plasma Proteomics Service Revenue by Application (2027-2032)
  9. 10.5 China Plasma Proteomics Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma Proteomics Service Revenue (2021-2032)
  2. 11.2 Asia Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasma Proteomics Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasma Proteomics Service Revenue by Type (2027-2032)
  5. 11.3 Asia Plasma Proteomics Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasma Proteomics Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasma Proteomics Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasma Proteomics Service Revenue by Application (2027-2032)
  9. 11.5 Asia Plasma Proteomics Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasma Proteomics Service Revenue by Country
  11. 11.6.1 Asia Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasma Proteomics Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasma Proteomics Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma Proteomics Service Revenue (2021-2032)
  2. 12.2 SAMEA Plasma Proteomics Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasma Proteomics Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasma Proteomics Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasma Proteomics Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasma Proteomics Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasma Proteomics Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasma Proteomics Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasma Proteomics Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasma Proteomics Service Revenue by Country
  11. 12.6.1 SAMEA Plasma Proteomics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasma Proteomics Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasma Proteomics Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst